IBDEI1KY ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,25253,0)
 ;;=G90.59^^107^1217^35
 ;;^UTILITY(U,$J,358.3,25253,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25253,1,3,0)
 ;;=3^Complex Regional Pain Syndrome I,Unspec
 ;;^UTILITY(U,$J,358.3,25253,1,4,0)
 ;;=4^G90.59
 ;;^UTILITY(U,$J,358.3,25253,2)
 ;;=^5004171
 ;;^UTILITY(U,$J,358.3,25254,0)
 ;;=G56.01^^107^1217^13
 ;;^UTILITY(U,$J,358.3,25254,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25254,1,3,0)
 ;;=3^Carpal Tunnel Syndrome,Right Upper Limb
 ;;^UTILITY(U,$J,358.3,25254,1,4,0)
 ;;=4^G56.01
 ;;^UTILITY(U,$J,358.3,25254,2)
 ;;=^5004018
 ;;^UTILITY(U,$J,358.3,25255,0)
 ;;=G56.02^^107^1217^12
 ;;^UTILITY(U,$J,358.3,25255,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25255,1,3,0)
 ;;=3^Carpal Tunnel Syndrome,Left Upper Limb
 ;;^UTILITY(U,$J,358.3,25255,1,4,0)
 ;;=4^G56.02
 ;;^UTILITY(U,$J,358.3,25255,2)
 ;;=^5004019
 ;;^UTILITY(U,$J,358.3,25256,0)
 ;;=G56.21^^107^1217^60
 ;;^UTILITY(U,$J,358.3,25256,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25256,1,3,0)
 ;;=3^Lesion of Ulnar Nerve,Right Upper Limb
 ;;^UTILITY(U,$J,358.3,25256,1,4,0)
 ;;=4^G56.21
 ;;^UTILITY(U,$J,358.3,25256,2)
 ;;=^5004024
 ;;^UTILITY(U,$J,358.3,25257,0)
 ;;=G56.22^^107^1217^59
 ;;^UTILITY(U,$J,358.3,25257,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25257,1,3,0)
 ;;=3^Lesion of Ulnar Nerve,Left Upper Limb
 ;;^UTILITY(U,$J,358.3,25257,1,4,0)
 ;;=4^G56.22
 ;;^UTILITY(U,$J,358.3,25257,2)
 ;;=^5004025
 ;;^UTILITY(U,$J,358.3,25258,0)
 ;;=L40.52^^107^1217^143
 ;;^UTILITY(U,$J,358.3,25258,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25258,1,3,0)
 ;;=3^Psoriatic Arthritis Mutilans
 ;;^UTILITY(U,$J,358.3,25258,1,4,0)
 ;;=4^L40.52
 ;;^UTILITY(U,$J,358.3,25258,2)
 ;;=^5009167
 ;;^UTILITY(U,$J,358.3,25259,0)
 ;;=L40.53^^107^1217^144
 ;;^UTILITY(U,$J,358.3,25259,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25259,1,3,0)
 ;;=3^Psoriatic Spondylitis
 ;;^UTILITY(U,$J,358.3,25259,1,4,0)
 ;;=4^L40.53
 ;;^UTILITY(U,$J,358.3,25259,2)
 ;;=^5009168
 ;;^UTILITY(U,$J,358.3,25260,0)
 ;;=M32.9^^107^1217^187
 ;;^UTILITY(U,$J,358.3,25260,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25260,1,3,0)
 ;;=3^Systemic Lupus Erythematosus,Unspec
 ;;^UTILITY(U,$J,358.3,25260,1,4,0)
 ;;=4^M32.9
 ;;^UTILITY(U,$J,358.3,25260,2)
 ;;=^5011761
 ;;^UTILITY(U,$J,358.3,25261,0)
 ;;=M32.0^^107^1217^183
 ;;^UTILITY(U,$J,358.3,25261,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25261,1,3,0)
 ;;=3^Systemic Lupus Erythematosus,Drug-Induced
 ;;^UTILITY(U,$J,358.3,25261,1,4,0)
 ;;=4^M32.0
 ;;^UTILITY(U,$J,358.3,25261,2)
 ;;=^5011752
 ;;^UTILITY(U,$J,358.3,25262,0)
 ;;=M32.13^^107^1217^185
 ;;^UTILITY(U,$J,358.3,25262,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25262,1,3,0)
 ;;=3^Systemic Lupus Erythematosus,Lung Involvement
 ;;^UTILITY(U,$J,358.3,25262,1,4,0)
 ;;=4^M32.13
 ;;^UTILITY(U,$J,358.3,25262,2)
 ;;=^5011756
 ;;^UTILITY(U,$J,358.3,25263,0)
 ;;=M32.14^^107^1217^184
 ;;^UTILITY(U,$J,358.3,25263,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25263,1,3,0)
 ;;=3^Systemic Lupus Erythematosus,Glomerular Disease
 ;;^UTILITY(U,$J,358.3,25263,1,4,0)
 ;;=4^M32.14
 ;;^UTILITY(U,$J,358.3,25263,2)
 ;;=^5011757
 ;;^UTILITY(U,$J,358.3,25264,0)
 ;;=M32.12^^107^1217^186
 ;;^UTILITY(U,$J,358.3,25264,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,25264,1,3,0)
 ;;=3^Systemic Lupus Erythematosus,Pericarditis
 ;;^UTILITY(U,$J,358.3,25264,1,4,0)
 ;;=4^M32.12
 ;;^UTILITY(U,$J,358.3,25264,2)
 ;;=^5011755
